Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatment
- 31 December 1995
- Vol. 13 (17) , 1643-1648
- https://doi.org/10.1016/0264-410x(95)00134-m
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Toxin inactivation and antigen stabilization: two different uses of formaldehydeVaccine, 1994
- Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHAVaccine, 1993
- Circulating cellular immune response to oral immunization of humans with cholera toxin B-subunitVaccine, 1993
- The mucosal immune system: from fundamental concepts to vaccine developmentVaccine, 1992
- Cholera as a model for research on mucosal immunity and development of oral vaccinesCurrent Opinion in Immunology, 1992
- The early cellular and humoral immune response to primary and booster oral immunization with cholera toxin B subunitEuropean Journal of Immunology, 1991
- Intranasal immunization using the B subunit of the Escherichia coli heat‐labile toxin fused to an epitope of the Bordetella pertussis P.69 antigenMolecular Microbiology, 1991
- Towards third-generation whooping cough vaccinesTrends in Biotechnology, 1991
- Novel nonreplicating antigen delivery systemsCurrent Opinion in Infectious Diseases, 1990
- Ir gene control of the murine secretory IgA response to cholera toxinEuropean Journal of Immunology, 1987